跳至主要内容
临床试验/NCT06157177
NCT06157177招募中4 期

Efficacy of Modified Release Metaxalone 640 mg in Acute Lumbosacral Musculoskeletal Conditions With Spinal Stenosis and Sciatica

Primus Pharmaceuticals43 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年11月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
50
试验地点
43
主要终点
Change of Numeric Pain Scale

研究概览

简要总结

The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about:

  • Amount and quality of pain
  • Interference with physical activity
  • Interference with sleep

详细描述

Double-blind, randomized, placebo-controlled, multi-center study of metaxalone 640 mg plus standard of care for patients with acute lumbo sacral musculoskeletal conditions with spinal stenosis and sciatica. Participants will be randomized 1:1. Following the initial pilot-study a second study will randomize a larger population of patients with appropriate power.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • No clinically significant conditions impacting quality or quantity of pain
  • Baseline Numeric Pain Scale ≥ 6
  • Capable of answering text or email survey reminders
  • Low back pain with or without sciatica

排除标准

  • Current use of other skeletal relaxants
  • Current use of other pain relievers
  • Current use of cimetidine or monoamine oxidase inhibitors

研究组 & 干预措施

Active M640

Active Comparator

Metaxalone micronized 640 mg over encapsulated tablet Taken orally every 6 hours for 7 days

干预措施: Metaxalone 640 mg Oral Tablet (Drug)

Placebo

Placebo Comparator

Inactive placebo capsule 640 mg Taken orally every 6 hours for 7 days

干预措施: Metaxalone 640 mg Oral Tablet (Drug)

结局指标

主要结局

Change of Numeric Pain Scale

时间窗: Day 1 to Day 7

Change from Baseline in low back pain and leg pain as measured by the Numeric Pain Rating Scale (NPRS) at Day 7

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (43)

Loading locations...

相似试验